Publication | Closed Access
Cost-Effectiveness of LDL-C Lowering With Evolocumab In Patients With High Cardiovascular Risk In The United States
62
Citations
2
References
2016
Year
Cardiovascular EpidemiologyHealth PolicyCardiovascular DiseaseHigh Cardiovascular RiskHyperlipidemiaPharmacoeconomicsPharmacotherapyDyslipidemiaPublic HealthMedicineUnited StatesAtherosclerosisEpidemiology
| Year | Citations | |
|---|---|---|
Page 1
Page 1